Design, Biological Characterization, and Discovery of the Brain-Penetrant NLRP3 Inhibitor Based on a [1,2,4]Triazolo[1,5- a ]pyrimidine Scaffold for the Treatment of Central Nervous System Diseases
Journal of Medicinal Chemistry · 09.07.2026 · 69 (13) · 15766-15785
DOI: 10.1021/acs.jmedchem.6c00839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 23.06.2026. Verfasst von Weiming He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Genescience Pharmaceutical Co., Ltd., 88 Hongcao Road, Xuhui District, Shanghai 200120, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Central Nervous System Diseases, Pyrimidines, Brain. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Changchun Genescience Pharmaceutical Co., Ltd., 88 Hongcao Road, Xuhui District, Shanghai 200120, China.
ORCID-Profile: Weiming He
Zitieren
APA
He, W., Zhang, K., Jia, X., Lv, Y., Cheng, T., Han, L., Xia, Y., Zhang, X., Zhai, W., Yang, F., Wang, S., & Jin, L. (2026). Design, Biological Characterization, and Discovery of the Brain-Penetrant NLRP3 Inhibitor Based on a [1,2,4]Triazolo[1,5- a ]pyrimidine Scaffold for the Treatment of Central Nervous System Diseases. Journal of Medicinal Chemistry, 69(13), 15766-15785. https://doi.org/10.1021/acs.jmedchem.6c00839
Vancouver
He W, Zhang K, Jia X, Lv Y, Cheng T, Han L, et al. Design, Biological Characterization, and Discovery of the Brain-Penetrant NLRP3 Inhibitor Based on a [1,2,4]Triazolo[1,5- a ]pyrimidine Scaffold for the Treatment of Central Nervous System Diseases. Journal of Medicinal Chemistry. 2026;69(13):15766-15785. doi:10.1021/acs.jmedchem.6c00839
BibTeX
@article{He2026,
author = {He, Weiming and Zhang, Kaili and Jia, Xiangyu and Lv, Yue and Cheng, Tao and Han, Long and Xia, Yuanfeng and Zhang, Xiaobing and Zhai, Wenqiang and Yang, Fanglong and Wang, Siqin and Jin, Lei},
title = {Design, Biological Characterization, and Discovery of the Brain-Penetrant NLRP3 Inhibitor Based on a [1,2,4]Triazolo[1,5- a ]pyrimidine Scaffold for the Treatment of Central Nervous System Diseases},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {13},
pages = {15766--15785},
doi = {10.1021/acs.jmedchem.6c00839}
}
EUVIMED